Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
Saved in:
| Title: | Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD. |
|---|---|
| Authors: | Gregg LP; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas., Richardson PA; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas., Nambi V; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Research and Cardiovascular Research Institute, Baylor College of Medicine, Michael E. DeBakey Veterans Affairs Hospital, Houston, Texas., Petersen LA; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas., Matheny ME; Geriatrics Research Education and Clinical Care Service, Tennessee Valley Healthcare System VA, Nashville, Tennessee.; Departments of Biomedical Informatics, Biostatistics, and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Virani SS; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Section of Cardiology, Department of Medicine, Aga Khan University, Karachi, Pakistan., Navaneethan SD; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas. |
| Source: | Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2025 Jan 01; Vol. 36 (1), pp. 87-98. Date of Electronic Publication: 2024 Aug 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39186372 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gregg+LP%22">Gregg LP</searchLink>; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Richardson+PA%22">Richardson PA</searchLink>; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Nambi+V%22">Nambi V</searchLink>; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Research and Cardiovascular Research Institute, Baylor College of Medicine, Michael E. DeBakey Veterans Affairs Hospital, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Petersen+LA%22">Petersen LA</searchLink>; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Matheny+ME%22">Matheny ME</searchLink>; Geriatrics Research Education and Clinical Care Service, Tennessee Valley Healthcare System VA, Nashville, Tennessee.; Departments of Biomedical Informatics, Biostatistics, and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Virani+SS%22">Virani SS</searchLink>; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Section of Cardiology, Department of Medicine, Aga Khan University, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Navaneethan+SD%22">Navaneethan SD</searchLink>; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229013836%22">Journal of the American Society of Nephrology : JASN</searchLink> [J Am Soc Nephrol] 2025 Jan 01; Vol. 36 (1), pp. 87-98. <i>Date of Electronic Publication: </i>2024 Aug 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+on+behalf+of+the+American+Society+of+Nephrology%22">Wolters Kluwer Health, on behalf of the American Society of Nephrology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9013836 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-3450 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210466673%22">10466673 </searchLink><i>NLM ISO Abbreviation: </i>J Am Soc Nephrol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39186372 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1681/ASN.0000000000000477 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 87 Titles: – TitleFull: Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gregg LP – PersonEntity: Name: NameFull: Richardson PA – PersonEntity: Name: NameFull: Nambi V – PersonEntity: Name: NameFull: Petersen LA – PersonEntity: Name: NameFull: Matheny ME – PersonEntity: Name: NameFull: Virani SS – PersonEntity: Name: NameFull: Navaneethan SD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1533-3450 Numbering: – Type: volume Value: 36 – Type: issue Value: 1 Titles: – TitleFull: Journal of the American Society of Nephrology : JASN Type: main |
| ResultId | 1 |